Novartis AG logo

Novartis AG - Registered Shares

3
1
XSWX:NOVN (Switzerland)   Registered Shares
CHF 88.94 (+1.81%) Apr 23
14.17
P/B:
4.50
Market Cap:
CHF 181.47B ($ 198.39B)
Enterprise V:
CHF 192.77B ($ 210.74B)
Volume:
8.28M
Avg Vol (2M):
3.46M
Also Trade In:
Volume:
8.28M
Avg Vol (2M):
3.46M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Novartis AG ( ) from 2001 to Apr 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Novartis AG stock (XSWX:NOVN) PE ratio as of Apr 24 2024 is 14.17. More Details

Novartis AG (XSWX:NOVN) PE Ratio (TTM) Chart

To

Novartis AG (XSWX:NOVN) PE Ratio (TTM) Historical Data

Total 1259
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Novartis AG PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-24 14.2 2024-02-21 14.3
2024-04-23 14.2 2024-02-20 14.5
2024-04-22 13.9 2024-02-19 14.3
2024-04-19 13.6 2024-02-16 14.1
2024-04-18 13.5 2024-02-15 14.0
2024-04-17 13.5 2024-02-14 14.0
2024-04-16 13.6 2024-02-13 14.0
2024-04-15 13.8 2024-02-12 14.0
2024-04-12 13.7 2024-02-09 14.1
2024-04-11 13.7 2024-02-08 14.0
2024-04-10 13.7 2024-02-07 14.5
2024-04-09 13.8 2024-02-06 14.4
2024-04-08 13.8 2024-02-05 14.4
2024-04-05 13.7 2024-02-02 14.3
2024-04-04 14.1 2024-02-01 14.4
2024-04-03 13.7 2024-01-31 14.3
2024-04-02 13.7 2024-01-30 14.8
2024-04-01 13.9 2024-01-29 14.8
2024-03-29 13.9 2024-01-26 14.7
2024-03-28 13.9 2024-01-25 14.8
2024-03-27 13.8 2024-01-24 14.9
2024-03-26 13.7 2024-01-23 14.9
2024-03-25 13.8 2024-01-22 15.0
2024-03-22 13.8 2024-01-19 14.9
2024-03-21 13.8 2024-01-18 14.8
2024-03-20 13.6 2024-01-17 14.9
2024-03-19 13.6 2024-01-16 14.8
2024-03-18 13.6 2024-01-15 14.7
2024-03-15 13.7 2024-01-12 14.6
2024-03-14 13.8 2024-01-11 14.6
2024-03-13 13.9 2024-01-10 14.6
2024-03-12 14.0 2024-01-09 14.5
2024-03-11 14.2 2024-01-08 14.5
2024-03-08 14.0 2024-01-05 14.4
2024-03-07 14.0 2024-01-04 14.3
2024-03-06 14.5 2024-01-03 14.1
2024-03-05 14.4 2024-01-02 13.5
2024-03-04 14.4 2024-01-01 13.5
2024-03-01 14.4 2023-12-29 13.5
2024-02-29 14.3 2023-12-28 13.4
2024-02-28 14.3 2023-12-27 24.8
2024-02-27 14.4 2023-12-26 25.0
2024-02-26 14.6 2023-12-25 25.0
2024-02-23 14.6 2023-12-22 25.0
2024-02-22 14.4 2023-12-21 24.8

Novartis AG (XSWX:NOVN) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.